In Brief: Thalidomide
Executive Summary
Thalidomide: Open public scientific workshop sponsored by FDA, the National Institutes of Health and the Centers for Disease Control and Prevention will discuss the potential benefits and risks of thalidomide use. The workshop will be held Sept. 9-10 at NIH's Natcher Conference Center in Bethesda, Md., starting at 8:30 a.m. the first day and 8 a.m. the second day. Participants should register by Aug. 29...